You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 16, 2025

Details for Patent: 11,219,662


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,219,662 protect, and when does it expire?

Patent 11,219,662 protects GIAPREZA and is included in one NDA.

This patent has eleven patent family members in ten countries.

Summary for Patent: 11,219,662
Title:Methods for treating hypotension in a patient that has received an ACE inhibitor by administering angiotensin II
Abstract:The present disclosure relates to the use of angiotensin II, angiotensin III, or angiotensin IV in therapeutic methods for the treatment of hypotension, especially catecholamine-resistant hypotension.
Inventor(s):George Tidmarsh, Lakhmir Chawla
Assignee:La Jolla Pharma LLC
Application Number:US17/192,453
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 11,219,662: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of United States Patent 11,219,662, exploring its claims, scope, and the broader patent landscape.

Understanding Patent Claims

Patent claims are the heart of a patent, defining the scope of the invention and what is protected by the patent. They are typically divided into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[3].

The Importance of Patent Scope

Patent scope is a critical aspect of patent quality and can significantly impact innovation and litigation. Metrics such as independent claim length and independent claim count can be used to measure patent scope. Narrower claims are often associated with a higher probability of grant and a shorter examination process[3].

Patent 11,219,662: Overview

To analyze the scope and claims of United States Patent 11,219,662, one must first identify the patent's classification, type, and the technology it pertains to. Here is a general approach to understanding this patent:

Classification and Type

Patents are classified into various categories such as utility, design, and plant patents. The classification helps in understanding the broader category under which the patent falls. For example, if the patent is a utility patent, it would be related to a functional invention[1].

Claims Analysis

  • Independent Claims: These define the core of the invention. Analyzing the language and breadth of these claims is essential to understand what is protected.
  • Dependent Claims: These further limit the independent claims and provide additional details about the invention.

Patent Landscape

Understanding the patent landscape involves looking at related patents, prior art, and the competitive environment. This can be done by searching through databases like the USPTO's Electronic Official Gazette or using tools like the Common Citation Document (CCD) which consolidates citation data from multiple patent offices[1].

Searching and Analyzing Patents

Using USPTO Resources

The United States Patent and Trademark Office (USPTO) provides several resources to search and analyze patents:

  • Patent and Trademark Resource Centers (PTRCs): These centers offer local search resources and training in patent search techniques.
  • Electronic Official Gazette: This allows users to browse through issued patents for the current week, categorized by classification or type of patent[1].

Common Citation Document (CCD)

The CCD application is particularly useful for international patents, as it provides a single point of access to citation data from the IP5 Offices (the USPTO, the European Patent Office, the Japan Patent Office, the Korean Intellectual Property Office, and the State Intellectual Property Office of China). This helps in visualizing the search results for the same invention produced by several offices on a single page[1].

Legal and Litigation Aspects

Patent infringement and validity are often subjects of legal disputes. Understanding the legal framework is crucial:

  • Infringement: Determining whether a patent has been infringed involves comparing the claims of the patent with the allegedly infringing product or process. This is often a question of fact reviewed for substantial evidence when tried to a jury[2].
  • Litigation: Patents can be the subject of extensive litigation, including motions for judgment as a matter of law and new trials. The outcomes of such cases can significantly impact the financial and strategic positions of the parties involved[2].

Small Claims Patent Court Considerations

In the context of patent disputes, there is ongoing discussion about the feasibility of a small claims patent court. Such a court would aim to provide a more accessible and cost-effective venue for resolving patent disputes, particularly for small inventors and businesses. The Administrative Conference of the United States (ACUS) has conducted studies on this topic, engaging with a wide range of stakeholders to assess the need and potential structure of such a court[5].

Key Metrics for Patent Scope

When analyzing the scope of a patent like 11,219,662, metrics such as independent claim length and independent claim count are useful:

  • Independent Claim Length: Longer independent claims may indicate broader or more complex inventions.
  • Independent Claim Count: A higher number of independent claims can suggest a more detailed and possibly narrower scope[3].

Practical Implications

Understanding the scope and claims of a patent has practical implications for businesses and inventors:

  • Licensing and Litigation: Broader patents may lead to increased licensing and litigation costs, while narrower patents might reduce these costs but also limit the protection offered[3].
  • Innovation Incentives: The clarity and validity of patent claims can influence innovation incentives. Clear and valid claims can encourage innovation by providing clear boundaries and protection[3].

Case Studies and Examples

Real-world cases can provide valuable insights into how patent claims and scope are interpreted and contested. For instance, the case of Provisur Technologies, Inc. v. Weber, Inc. highlights the importance of substantial evidence in determining infringement and the role of patent claims in litigation[2].

Highlight: Importance of Clear Claims

"Patent scope is one of the important aspects in the debates over 'patent quality.' The purported decrease in patent quality over the past decade or two has supposedly led to granting patents of increased breadth (or 'overly broad' patents), decreased clarity, and questionable validity." - Source: SSRN Paper on Patent Claims and Patent Scope[3]

Key Takeaways

  • Patent Claims: Independent and dependent claims define the invention and its scope.
  • Patent Scope: Metrics like independent claim length and count help measure patent scope.
  • Legal Framework: Infringement and validity are critical legal aspects.
  • Practical Implications: Clear and valid claims impact licensing, litigation, and innovation incentives.
  • Resources: USPTO resources and tools like CCD are essential for analysis.

FAQs

What is the purpose of independent claims in a patent?

Independent claims define the core of the invention and stand alone, while dependent claims further limit these independent claims.

How can the scope of a patent be measured?

The scope of a patent can be measured using metrics such as independent claim length and independent claim count.

What is the Common Citation Document (CCD)?

The CCD provides a single point of access to citation data from the IP5 Offices, consolidating prior art cited by all participating offices for the family members of a patent application.

Why is patent scope important?

Patent scope is crucial as it affects licensing and litigation costs, innovation incentives, and the overall validity and clarity of the patent.

What is the role of the USPTO in patent searches?

The USPTO provides resources such as PTRCs, the Electronic Official Gazette, and other tools to facilitate patent searches and analysis.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. Provisur Technologies, Inc. v. Weber, Inc.: https://cafc.uscourts.gov/opinions-orders/23-1438.OPINION.10-2-2024_2394588.pdf
  3. SSRN - Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. Innoviva INC - Form 10-Q: https://investor.inva.com/static-files/45c16890-4ed5-4171-94f2-7f0c801fcfbd
  5. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,219,662

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
La Jolla Pharma GIAPREZA angiotensin ii acetate SOLUTION;INTRAVENOUS 209360-003 Dec 23, 2021 RX Yes Yes 11,219,662 ⤷  Try for Free TREATING HYPOTENSION WITH ANGIOTENSIN II IN A PATIENT RECEIVING AN ANGIOTENSIN CONVERTING ENZYME INHIBITOR ⤷  Try for Free
La Jolla Pharma GIAPREZA angiotensin ii acetate SOLUTION;INTRAVENOUS 209360-001 Dec 21, 2017 RX Yes Yes 11,219,662 ⤷  Try for Free TREATING HYPOTENSION WITH ANGIOTENSIN II IN A PATIENT RECEIVING AN ANGIOTENSIN CONVERTING ENZYME INHIBITOR ⤷  Try for Free
La Jolla Pharma GIAPREZA angiotensin ii acetate SOLUTION;INTRAVENOUS 209360-002 Dec 21, 2017 DISCN Yes No 11,219,662 ⤷  Try for Free TREATING HYPOTENSION WITH ANGIOTENSIN II IN A PATIENT RECEIVING AN ANGIOTENSIN CONVERTING ENZYME INHIBITOR ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,219,662

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2017205168 ⤷  Try for Free
Australia 2024201059 ⤷  Try for Free
Brazil 112018013847 ⤷  Try for Free
Canada 3010781 ⤷  Try for Free
European Patent Office 3400000 ⤷  Try for Free
Spain 2973280 ⤷  Try for Free
Japan 2019501201 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.